2020 Q1 Form 10-Q Financial Statement

#000155837020004923 Filed on May 01, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $4.104M $3.458M
YoY Change 18.68% -70.67%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.418M $6.938M
YoY Change 21.33% -3.64%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $493.0K $468.0K
YoY Change 5.34% -48.0%
% of Gross Profit
Operating Expenses $8.418M $6.938M
YoY Change 21.33% -26.97%
Operating Profit -$7.275M -$6.201M
YoY Change 17.32% -376.09%
Interest Expense $5.861M $6.543M
YoY Change -10.42% 45.4%
% of Operating Profit
Other Income/Expense, Net $163.0K $423.0K
YoY Change -61.47%
Pretax Income -$10.62M -$18.88M
YoY Change -43.76% -5.63%
Income Tax -$2.774M -$4.574M
% Of Pretax Income
Net Earnings -$7.842M -$14.30M
YoY Change -45.16% -5.1%
Net Earnings / Revenue -191.08% -413.56%
Basic Earnings Per Share -$0.04 -$0.08
Diluted Earnings Per Share -$0.04 -$0.08
COMMON SHARES
Basic Shares Outstanding 181.9M 181.4M
Diluted Shares Outstanding 182.8M 182.7M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.00M $73.00M
YoY Change -75.34% -6.41%
Cash & Equivalents $18.36M $73.18M
Short-Term Investments
Other Short-Term Assets $2.665M $1.000M
YoY Change 166.5% -50.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $21.02M $74.00M
YoY Change -71.59% -7.5%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.19B $12.00B
YoY Change 1.63% 1.12%
Other Assets $9.406M $10.00M
YoY Change -5.94%
Total Long-Term Assets $12.20B $12.01B
YoY Change 1.62% 1.1%
TOTAL ASSETS
Total Short-Term Assets $21.02M $74.00M
Total Long-Term Assets $12.20B $12.01B
Total Assets $12.23B $12.08B
YoY Change 1.18% 1.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.000M $3.000M
YoY Change 33.33% 0.0%
Accrued Expenses
YoY Change
Deferred Revenue $4.300M
YoY Change -4.44%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.110M $6.000M
YoY Change 35.17% 20.0%
LONG-TERM LIABILITIES
Long-Term Debt $573.0M $523.0M
YoY Change 9.56% 5.02%
Other Long-Term Liabilities $4.100M $3.000M
YoY Change 36.67% 0.0%
Total Long-Term Liabilities $4.100M $526.0M
YoY Change -99.22% 4.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.110M $6.000M
Total Long-Term Liabilities $4.100M $526.0M
Total Liabilities $1.578B $1.494B
YoY Change 5.63% 3.32%
SHAREHOLDERS EQUITY
Retained Earnings $2.760B
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.65B $10.59B
YoY Change
Total Liabilities & Shareholders Equity $12.23B $12.08B
YoY Change 1.18% 1.05%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$7.842M -$14.30M
YoY Change -45.16% -5.1%
Depreciation, Depletion And Amortization $493.0K $468.0K
YoY Change 5.34% -48.0%
Cash From Operating Activities -$14.50M -$11.56M
YoY Change 25.43% 212.46%
INVESTING ACTIVITIES
Capital Expenditures $15.00K $17.00K
YoY Change -11.76%
Acquisitions
YoY Change
Other Investing Activities -$14.90M
YoY Change
Cash From Investing Activities -$14.93M -$17.00K
YoY Change 87694.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.941M 1.653M
YoY Change -217.42% 230.6%
NET CHANGE
Cash From Operating Activities -14.50M -11.56M
Cash From Investing Activities -14.93M -17.00K
Cash From Financing Activities -1.941M 1.653M
Net Change In Cash -31.37M -9.925M
YoY Change 216.04% 210.16%
FREE CASH FLOW
Cash From Operating Activities -$14.50M -$11.56M
Capital Expenditures $15.00K $17.00K
Free Cash Flow -$14.52M -$11.58M
YoY Change 25.38% 212.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001611983
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-36713
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
LIBERTY BROADBAND CORPORATION
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1211994
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
12300 Liberty Boulevard
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Englewood
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80112
CY2020Q1 dei City Area Code
CityAreaCode
720
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
875-5700
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18357000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49724000
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2665000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2409000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
21022000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
52133000
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
12194726000
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
12194674000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9406000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9535000
CY2020Q1 us-gaap Assets
Assets
12225154000
CY2019Q4 us-gaap Assets
Assets
12256342000
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4260000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6168000
CY2020Q1 lbrda Deferred Revenue And Other Current Liabilities
DeferredRevenueAndOtherCurrentLiabilities
3850000
CY2019Q4 lbrda Deferred Revenue And Other Current Liabilities
DeferredRevenueAndOtherCurrentLiabilities
5971000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8110000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12139000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
573269000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
572944000
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
992704000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
999757000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4100000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3556000
CY2020Q1 us-gaap Liabilities
Liabilities
1578183000
CY2019Q4 us-gaap Liabilities
Liabilities
1588396000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7876950000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7890084000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8158000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8158000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2760043000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2767885000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
10646971000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
10667946000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12225154000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12256342000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4104000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3458000
CY2020Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2468000
CY2019Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2253000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8418000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6938000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
493000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
468000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
11379000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
9659000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7275000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6201000
CY2020Q1 us-gaap Interest Expense
InterestExpense
5861000
CY2019Q1 us-gaap Interest Expense
InterestExpense
6543000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
61682000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
34849000
CY2020Q1 us-gaap Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income
GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome
-59325000
CY2020Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-4066000
CY2019Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-2975000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14501000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11561000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000
CY2020Q1 lbrda Payments For Exercise Of Preemptive Right To Purchase Charter Shares
PaymentsForExerciseOfPreemptiveRightToPurchaseCharterShares
14910000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14925000
CY2019Q1 us-gaap Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income
GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome
-41403000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
163000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
423000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10616000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18875000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2774000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4574000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7842000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-14301000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-7842000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-14301000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
493000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
468000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1801000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2616000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
61682000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
34849000
CY2020Q1 us-gaap Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income
GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome
-59325000
CY2019Q1 us-gaap Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income
GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome
-41403000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2774000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4574000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-436000
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-302000
CY2020Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
192000
CY2019Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-349000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1944000
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
3000
CY2019Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1653000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1941000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1653000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-31367000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9925000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49724000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83103000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18357000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73178000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
10667946000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7842000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1805000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1944000
CY2020Q1 lbrda Noncontrolling Interest Activity In Subsidiary
NoncontrollingInterestActivityInSubsidiary
-12997000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
10646971000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
10598618000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-14301000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2523000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1653000
CY2019Q1 lbrda Noncontrolling Interest Activity In Subsidiary
NoncontrollingInterestActivityInSubsidiary
1262000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
10589755000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
181902000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
181366000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
906000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1299000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
182808000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
182665000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1801000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2616000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4104000
CY2020Q1 lbrda Adjusted Operating Income Before Depreciation And Amortization
AdjustedOperatingIncomeBeforeDepreciationAndAmortization
-4981000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3458000
CY2019Q1 lbrda Adjusted Operating Income Before Depreciation And Amortization
AdjustedOperatingIncomeBeforeDepreciationAndAmortization
-3117000
CY2020Q1 us-gaap Assets
Assets
12225154000
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
12194726000
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
15000
CY2020Q1 lbrda Adjusted Operating Income Before Depreciation And Amortization
AdjustedOperatingIncomeBeforeDepreciationAndAmortization
-4981000
CY2019Q1 lbrda Adjusted Operating Income Before Depreciation And Amortization
AdjustedOperatingIncomeBeforeDepreciationAndAmortization
-3117000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1801000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2616000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
493000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
468000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7275000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6201000
CY2020Q1 us-gaap Interest Expense
InterestExpense
5861000
CY2019Q1 us-gaap Interest Expense
InterestExpense
6543000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
61682000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
34849000
CY2020Q1 us-gaap Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income
GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome
-59325000
CY2019Q1 us-gaap Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income
GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome
-41403000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
163000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
423000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10616000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18875000

Files In Submission

Name View Source Status
0001558370-20-004923-index-headers.html Edgar Link pending
0001558370-20-004923-index.html Edgar Link pending
0001558370-20-004923.txt Edgar Link pending
0001558370-20-004923-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lbrda-20200331xex31d1.htm Edgar Link pending
lbrda-20200331xex31d2.htm Edgar Link pending
lbrda-20200331xex32.htm Edgar Link pending
lbrda-20200501.xsd Edgar Link pending
lbrda-20200501x10q.htm Edgar Link pending
lbrda-20200501x10q_htm.xml Edgar Link completed
lbrda-20200501_cal.xml Edgar Link unprocessable
lbrda-20200501_def.xml Edgar Link unprocessable
lbrda-20200501_lab.xml Edgar Link unprocessable
lbrda-20200501_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending